Jci_page_head_homepage_01 Jci_page_head_homepage_02
Meizi Jiang, Hideaki Bujo, Kenji Ohwaki, Hiroyuki Unoki, Hiroyuki Yamazaki, Tatsuro Kanaki, Manabu Shibasaki, Kazuhiko Azuma, Kenichi Harigaya, Wolfgang J. Schneider, Yasushi Saito
Published in Volume 118, Issue 8
J Clin Invest. 2008; 118(8):2733–2746 doi:10.1172/JCI32381
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 9
Ang II–induced LR11/uPAR pathway in SMCs.

(A) uPAR expression in Lr11–/– SMCs. Membrane extracts of Lr11+/+ SMCs or Lr11–/– SMCs were incubated with or without Ang II (1 μM) in the presence or absence of sLR11 (1 μg/μl) and subjected to immunoblot analysis using anti-uPAR (~50 kDa) antibody. Blot shown is representative of 3 independent experiments. Data are presented as mean ± SD (n = 3). *P < 0.05. (B) Effect of blocking the LR11/uPAR pathway on the Ang II–dependent increase of Rac1 activation in rabbit SMCs. Cell lysates (60 μg protein) were incubated in the presence or absence of Ang II (1 μM) with or without valsartan (10 nM), anti-LR11 antibody, or anti-uPAR antibody, immunoprecipitated with PAK-1 PBD Protein GST beads, and subjected to immunoblot analysis using anti-Rac1 (~21 kDa) antibody. Blot shown is representative of 3 independent experiments. Data are presented as mean ± SD (n = 3). (C) Effect of ARB on the Ang II–dependent increase of Rac1 activation in Lr11–/– SMCs. Cell lysate (60 μg protein) of Lr11+/+ or Lr11–/– SMCs was incubated in the presence or absence of Ang II (1 μM) with or without candesartan (10 nM) or sLR11 (1 μg/μl), immunoprecipitated with PAK-1 PBD Protein GST beads, and subjected to immunoblot analysis using anti-Rac1 (~21 kDa) antibody. Blot shown is representative of 3 independent experiments. Data are presented as mean ± SD (n = 3).